Galmed Pharmaceuticals Lt... (GLMD)
NASDAQ: GLMD
· Real-Time Price · USD
1.55
0.11 (7.64%)
At close: Aug 18, 2025, 3:59 PM
1.38
-10.97%
Pre-market: Aug 19, 2025, 06:17 AM EDT
7.64% (1D)
| Bid | 1.38 |
| Market Cap | 3.5M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -7.35M |
| EPS (ttm) | -6.6 |
| PE Ratio (ttm) | -0.23 |
| Forward PE | -1.68 |
| Analyst | n/a |
| Ask | 1.58 |
| Volume | 188,429 |
| Avg. Volume (20D) | 316,927 |
| Open | 1.46 |
| Previous Close | 1.44 |
| Day's Range | 1.46 - 1.58 |
| 52-Week Range | 1.15 - 23.80 |
| Beta | 0.58 |
About GLMD
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol GLMD
Website n/a
3 months ago
+10.61%
Galmed Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
10 months ago
-11.93%
Galmed Pharmaceuticals shares are trading lower. The company announced that results of its Phase 3 trial of Aramchol in 150 patients with NASH and fibrosis has been published in Hepatology.
